Publication Name	World Journal of Stem Cells
Manuscript ID	35363
Country	Switzerland

Received	2017-07-11 05:29
Peer-Review Started	2017-07-14 00:31
To Make the First Decision	2017-08-04 01:58
Return for Revision	2017-08-07 06:57
Revised	2017-08-14 13:53
Second Decision	2017-08-28 09:26
Accepted by Journal Editor-in-Chief	2017-08-29 00:21
Accepted by Company Editor-in-Chief	2017-09-04 18:15
Articles in Press	2017-09-04 18:15
Publication Fee Transferred	2017-09-07 09:06
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-10-23 07:17
Publish the Manuscript Online	2017-10-24 02:59

ISSN	1948-0210 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cell Biology
Manuscript Type	Minireviews
Article Title	Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy
Manuscript Source	Unsolicited Manuscript
All Author List	Ramin Radpour
ORCID	Author(s) ORCID Number Ramin Radpour http://orcid.org/0000-0002-5632-7833
Funding Agency and Grant Number
Corresponding Author	Ramin Radpour, MSc, PhD, Tumor Immunology and Cancer Stem Cells, Inselspital, Bern University Hospital, Department of Clinical Research, University Hospital Bern, Murtenstrasse 35, Bern 3008, Switzerland. ramin.radpour@dkf.unibe.ch
Key Words	Cancer stem cells; Cancer recurrence; Cancer therapy; Combination therapy; Chemotherapy; Radiation therapy; Immunotherapy
Core Tip	Cancer stem cells (CSCs) are small subpopulation of the tumor that can survive from conventional treatment, scape from the immune system and can cause recurrence of cancer disease. Therefore, any attempt in detection and selective therapeutic targeting of CSCs will ultimately lead to better cancer treatments and can play an im¬portant role in reducing the cancer related mortalities. This review highlights the trends and approaches in CSC tracing, isolating, characterizing and targeting, which are key strategies for a novel personalized molecular cancer therapy.
Publish Date	2017-10-24 02:59
Citation	Radpour R. Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy. World J Stem Cells 2017; 9(10): 169-178
URL	http://www.wjgnet.com/1948-0210/full/v9/i10/169.htm
DOI	http://dx.doi.org/10.4252/wjsc.v9.i10.169

Full Article (PDF)	WJSC-9-169.pdf
Full Article (Word)	WJSC-9-169.doc
Manuscript File	35363-Review.docx
Answering Reviewers	35363-Answering reviewers.pdf
Audio Core Tip	35363-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	35363-Conflict-of-interest statement.pdf
Copyright License Agreement	35363-Copyright assignment.pdf
Peer-review Report	35363-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	35363-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	35363-Scientific misconduct check.pdf
Scientific Editor Work List	35363-Scientific editor work list.pdf